Loading...
•
Mar 31, 2022
AbCellera Q1 2022 Earnings Report
AbCellera reported strong Q1 2022 results, driven by revenue growth and advancements in drug discovery programs.
Key Takeaways
AbCellera announced financial results for the first quarter of 2022, with total revenue of $317 million and net earnings of $169 million. The company saw growth in program starts and molecules advancing into the clinic.
Total revenue was $317 million, compared to $203 million in Q1 2021.
Net earnings were $0.59 per share on a basic and $0.54 on a diluted basis.
Six program starts in the quarter, bringing the cumulative total to 84.
One new molecule advanced into the clinic, bringing the cumulative total to six.
AbCellera
AbCellera
AbCellera Revenue by Segment
Revenue by Segment
Research Fees Revenue
CapyFin.comLicensing Revenue
CapyFin.com Forward Guidance
No specific forward guidance was provided in the earnings report.
Revenue & Expenses
Visualization of income flow from segment revenue to net income